LO3 Capital, a private investment firm, has announced its provision of a senior subordinated debt investment to Empower Pharmacy. This investment aims to support Empower, a leading compounding pharmacy and FDA registered outsourcing facility, with growth capital.
Empower, based in Houston, Texas, is known as the premier compounding pharmacy and outsourcing facility in the United States. Led by founder Shaun Noorian, the company offers personalized medicine solutions to patients, providers, and pharmacies in the health and wellness markets. Their innovative pharmaceutical solutions have garnered a strong customer base, serving over 15,000 prescribers and 2,000 institutions across all 50 states.
Shaun Noorian, President and CEO of Empower, expressed enthusiasm regarding the partnership with LO3 Capital and other investors. He stated that with LO3’s flexible capital, Empower can invest in their people, technology, and infrastructure to further expand their reach to patients and healthcare providers. Noorian believes that these investments will enhance patient access to quality and affordable compounded medications.
Glenn Harrison, LO3’s managing partner, commended Empower as a clear leader in the compounding pharmacy industry. He specifically praised the talented, founder-led management team and expressed confidence in Empower’s ability to succeed in the ever-evolving healthcare landscape.
LO3 Capital is a minority-owned private investment firm dedicated to supporting the growth of lower-middle market companies. With offices in Nashville, New York, and Dallas, the firm targets businesses with over $3 million of EBITDA across various industries. LO3 Capital collaborates with management teams, business owners, and private equity firms to provide capital for organic growth, acquisitions, recapitalizations, and ownership transitions.
This investment in Empower Pharmacy showcases LO3 Capital’s commitment to transformative capital and its belief in Empower’s potential to make a significant impact in the healthcare industry.
Sources:
– LO3 Capital LLC, PR Newswire
